Home › Trial NCT04598321
BrUOG 390: Neoadjuvant Treatment With Talazoparib
- Trial IDNCT04598321
- StatusTerminated
- PhasePhase 1
- Study typeInterventional
- SponsorBrown University
- Enrollment1
- Start date2021-03-29
- ConditionsBRCA1 Mutation · BRCA2 Mutation · Ovarian Cancer · Fallopian Tube Cancer · High Grade Serous Carcinoma
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.